Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

Go back to Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results
(NASDAQ: DNTH) Delayed: 87.50 +5.01 (6.07%)
Previous Close $82.49    52 Week High
Open $85.16    52 Week Low
Day High $88.41    P/E N/A 
Day Low $83.91    EPS
Volume 741,675